PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Nordic Capital acquires majority share in medtech corpuls

Nordic Capital is to acquire a majority share in corpuls, a medical technology company specialising in emergency medical solutions and cardiac resuscitation, with a key focus on the external defibrillator segment. 

Nordic Capital is to acquire a majority share in corpuls, a medical technology company specialising in emergency medical solutions and cardiac resuscitation, with a key focus on the external defibrillator segment. 

 

The founding family of corpuls will remain invested in the company and represented on the management board. 

corpuls develops a range of medical products and solutions, including advanced life support defibrillators and monitoring devices, automated external defibrillators, chest compression devices as well as telemedicine and software solutions. The products are designed to support professional users, such as emergency medical professionals in delivering critical care to patients under demanding circumstances. 

Nordic Capital has more than 30 years of experience in supporting the growth of healthcare and technology companies globally, and is an active investor in the DACH region. 

Previous Nordic Capital investments include companies such as The Binding Site, a global leader in specialty diagnostics,  Equashield, a leading global provider of closed system transfer devices designed to protect healthcare professionals from exposure to hazardous drugs, Advanz Pharma, a global speciality pharmaceutical company, and Sunrise Medical, a global leader within rehab mobility solutions.
 
The transaction is subject to customary closing conditions, including relevant regulatory approvals with completion being expected at the end of Q2 or the beginning of Q3 2023.
 

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured